1-3 of 3
Sze Ting Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study

Allison Barraclough, Sze Ting Lee, Melinda Burgess, Leonid Churilov, Geoff Chong, Denise Lee, Michael Gilbertson, Tineke Fancourt, Kate Manos, David S. Ritchie, Rachel M. Koldej, Andrew M. Scott, Colm Keane, Eliza A. Hawkes
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1432–1441.
https://doi.org/10.1182/bloodadvances.2024015487
Published: 2025
Includes: Supplemental data
Journal Articles

PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma

Genevieve Douglas, Zoe Loh, Evonne S.Y. Shum, Sze-Ting Lee, Niamh Waters, Garry Hamilton, Geoffrey Chong, Alexandra C. Murphy, Eliza A. Hawkes
Journal: Blood Advances
Blood Adv (2025) 9 (3): 499–506.
https://doi.org/10.1182/bloodadvances.2024013620
Published: 2025
Includes: Supplemental data
Journal Articles

Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma

Shin Hnin Wai, Sze Ting Lee, Edward R. Scheffer Cliff, Michael Bei, Jiwoo Lee, Eliza A. Hawkes, Geoffrey Chong
Journal: Blood Advances
Blood Adv (2024) 8 (3): 736–745.
https://doi.org/10.1182/bloodadvances.2023011566
Published: 2024
Includes: Supplemental data